Navigation Links
Massachusetts General Hospital leading nationwide, comparative study of common bipolar medications
Date:1/20/2011

The Massachusetts General Hospital (MGH) Bipolar Clinic and Research Program with the Bipolar Trials Network is launching Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness), a 10-site nationwide trial evaluating the real-world advantages and disadvantages of quetiapine, a widely prescribed second generation antipsychotic mood stabilizing medication, compared to lithium, the gold standard mood stabilizer, for the treatment of outpatients with bipolar disorder. The study is funded by a $10 million grant from the Agency for Healthcare Research Quality (AHRQ).

Bipolar disorder is a lifelong and highly recurrent mood disorder characterized by episodes of mania or hypomania that alternate with episodes of major depression. It is among the top 10 causes of disability worldwide, with associated costs of $70.6 billion per year for treatment and prevention.

"Studies that compare treatments for bipolar disorder usually don't allow participants to take other medications, but most patients need about three medications to feel well and stay well. Bipolar CHOICE is unique because participants can be treated not only with quetiapine or lithium, but with almost any other medication except other antipsychotics in order to help them feel better," says Andrew A. Nierenberg, MD, director of the MGH Bipolar Research Program and the principal investigator of Bipolar CHOICE.

Over the past 10 years, the pharmacologic treatments for bipolar disorder have shifted away from lithium which is available as a generic medication in favor of newly developed antipsychotics, such as quetiapine. Both drugs have well documented side effects. Quetiapine has the risk of drowsiness, weight gain, and increases the risk of cardiovascular disease. Lithium is associated with the risk of long-term thyroid and kidney problems.

"A real-world effectiveness study may uncover considerable differences regarding the risks of adverse effec
'/>"/>

Contact: Jennifer Gundersen Harris
jgundersen1@partners.org
617-724-6433
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Massachusetts Hospital Agrees to Pay U.S. $2.79 Million to Resolve False Claims Act Allegations
2. Diabetics Twice as Likely to Have Hearing Loss; Massachusetts HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March
3. Elements Therapeutic Massage Announces Franchise Expansion Plan for Massachusetts
4. Miles for Hope’s Moving Towards A Cure(SM) Brain Tumor Walk in Boston Raising Funds for Brain Tumor Vaccine and Massachusetts General Hospital
5. Massachusetts health care reform reviewed as a model for national plan
6. Firefighters Walk Over 60,000 Miles in Blue Cross Blue Shield of Massachusetts' Fitness Challenge
7. Blue Cross Blue Shield of Massachusetts Demonstrates Community Commitment with Fifth William C. Van Faasen Community Service Sabbatical
8. Blue Cross Blue Shield of Massachusetts and Northeast Health Systems Physician Hospital Organization Sign Alternative Quality Contract
9. Doctors hard to find for patients in Massachusetts first for-profit health plan
10. Massachusetts Institute of Technology IDs new cancer drug target
11. Massachusetts physician groups improving patient experience, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Federally Qualified Health Centers (FQHCs) granted new patient ... higher rates than other primary care practices (non-FQHCs), ... to results of a new 10-state University of ... Care . , Using data from a previous ... the investigators found that FQHCs community health ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Glycodrive ... Star Nutraceuticals designed to help maximize lean, strong muscle ... the body’s absorption of glucose has caught the attention ... “The main purpose behind Glycodrive is to help the ... muscle,” reports Michaels. “Carbs are essential in the muscle-building ...
(Date:9/30/2014)... N.C. (PRWEB) September 30, 2014 The ... an option to help diabetics curb their sweet tooth, ... Nature this September, suggests that zero-calorie sweeteners ... type 2 diabetes. , The Weizmann Institute of ... they fed artificial sweeteners to mice, the mice developed ...
(Date:9/30/2014)... 2014 With the flu season ... every day, it’s a perfect time to announce ... system is an electro-static disinfectant delivery system that ... normally missed with spray-on disinfectant applicators. , The ... an electrostatic negative charge to the disinfecting solution. ...
(Date:9/30/2014)... September 30, 2014 Two revolutionary procedures now ... treatment of gum disease a far less painful and ... , “If you’ve ever felt electric shock waves surge through ... a cold beverage, it’s possible you already know the impact ... is a general dentist in West Palm Beach, and a ...
Breaking Medicine News(10 mins):Health News:Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Columbus Janitorial Company Announces New Disinfecting System for your workplace 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3
... and Bioengineering (NIBIB) Laboratory of Bioengineering and Physical Science ... visualize fine details of cell structure three-dimensionally in thick ... organized and how they function. The work is described ... Nature Methods . The new electron tomography ...
... , , ... GTIV ), a leading provider of comprehensive home health ... the Company,s Board of Directors: Philip R. Lochner, Jr., Sheldon ... appointments, Gentiva has re-established an independent majority on its Board ...
... - NUCRYST Pharmaceuticals, a developer and manufacturer of ... Wound Management division of Smith Nephew ... Flex3 and Acticoat(TM) Flex7. The Flex range is ... dressings with NUCRYST,s proprietary SILCRYST(TM) nanocrystalline silver coatings. ...
... , , NEW YORK, Sept. ... is hosting a kick off cocktail reception to announce its Second ... the National Football League. The main event, The Journey of ... Rock Cafe with actress Lorraine Bracco and comedian Penny Marshall serving ...
... CAMBRIDGE, Mass., Sept. 3 Satori Pharmaceuticals Incorporated ... disease, Parkinson,s disease, and other neurodegenerative disorders, today announced that ... its Board of Directors. , , "We ... to our board," said Dr. Jeffrey Ives, Satori CEO. ...
... , , MIAMI BEACH, ... Oprah have spent years yo-yo dieting, but would they work so ... the extra pounds? These days, Fat is Fabulous, with reality shows ... zaftig women competing in dance-offs, bringing in big ratings numbers for ...
Cached Medicine News:Health News:NIBIB scientists increase imaging efficiency in cell structure studies 2Health News:Gentiva(R) Health Services Announces Appointment of Three Independent Directors 2Health News:Gentiva(R) Health Services Announces Appointment of Three Independent Directors 3Health News:Gentiva(R) Health Services Announces Appointment of Three Independent Directors 4Health News:Gentiva(R) Health Services Announces Appointment of Three Independent Directors 5Health News:Gentiva(R) Health Services Announces Appointment of Three Independent Directors 6Health News:European Launch of Acticoat(TM) Flex with NUCRYST's Nanocrystalline Silver Technology Announced by Smith Nephew 2Health News:European Launch of Acticoat(TM) Flex with NUCRYST's Nanocrystalline Silver Technology Announced by Smith Nephew 3Health News:European Launch of Acticoat(TM) Flex with NUCRYST's Nanocrystalline Silver Technology Announced by Smith Nephew 4Health News:Brain Injury Association of New York State to Host Kick Off Cocktail Reception 2Health News:Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors 2Health News:Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors 3Health News:Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors 4Health News:85% of Single Men Would Date Heavy Women; 90% of Single Women Feel Men Can't See Past a Few Extra Pounds, States Date.com 2Health News:85% of Single Men Would Date Heavy Women; 90% of Single Women Feel Men Can't See Past a Few Extra Pounds, States Date.com 3Health News:85% of Single Men Would Date Heavy Women; 90% of Single Women Feel Men Can't See Past a Few Extra Pounds, States Date.com 4
(Date:9/30/2014)... September 30, 2014 ... the "Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, ... and Reagents], Application (Immunology, Oncology) & by ... published by MarketsandMarkets, provides a detailed overview ... current market trends, and strategies impacting the ...
(Date:9/30/2014)... YORK , Sept. 30, 2014 The ... Growing ageing population and rise in the incidence of ... chronic wounds and in affordability of better quality of ... wound care market. Universal coverage of public health insurance ... would further stimulate demand. Based on the findings of ...
(Date:9/30/2014)... 2014 BioStructures, LLC has been awarded ... Tissue Banks (AATB), it was announced today by ... Accreditation follows an intensive nine-month process, including ... inspector.  It establishes that the level of medical, ... or exceeds the standards set by the AATB.  ...
Breaking Medicine Technology:Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4China Wound Care Market 2China Wound Care Market 3Biostructures, LLC Earns AATB Accreditation 2
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Medicine Products: